https://scholars.lib.ntu.edu.tw/handle/123456789/560104
標題: | Risk factor screening scale to optimize treatment for potential heart transplant candidates under extracorporeal membrane oxygenation | 作者: | YIH-SHARNG CHEN Ko W.-J. NAI-HSIN CHI I-HUI WU SHU-CHIEN HUANG Chen R.J.-C. NAI-KUAN CHOU RON-BIN HSU Lin F.-Y. SHOEI-SHEN WANG Chu S.-H. HSI-YU YU |
公開日期: | 2004 | 卷: | 4 | 期: | 11 | 起(迄)頁: | 1818-1825 | 來源出版物: | American Journal of Transplantation | 摘要: | We developed a risk factor-scaling score (RFSS) to select which patients supported by extracorporeal membrane oxygenation (ECMO) were suitable for ventricular assist device (VAD) implantation or heart transplantation (HTx). A total of 78 patients supported with ECMO for more than 48 h due to cardiac origin were included in this study. Patients were categorized into two groups based on the outcomes: the poor outcome group (n = 33) consisted of for those who later died or were later excluded from VAD or HTx; the favorable outcome group (n = 45) consisted of those who were weaned off ECMO finally and survived or were deemed suitable candidates for VAD or HTx. Seven risk factors were significant according to univariate analyses. Based on the regression coefficients of multivariate analysis, the RFSS was developed: (lung dysfunction × 7) + (systemic infection ×) + (peak lactate > 3 mmole/L × 3) + (kidney dysfunction × 2) + (creatine kinase > 10 000 U/L × 1). Patients with an RFSS of 7 or more were be allocated to the poor outcome group. The RFSS was validated by another group of 30 patients with good correlation. The RFSS provides a way to predict which ECMO-supported patients are suitable candidates for VAD implantation or HTx. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-7244221746&doi=10.1111%2fj.1600-6143.2004.00578.x&partnerID=40&md5=113a9153e08c9850e95b776e971d850a https://scholars.lib.ntu.edu.tw/handle/123456789/560104 |
ISSN: | 1600-6135 | DOI: | 10.1111/j.1600-6143.2004.00578.x | SDG/關鍵字: | adolescent; adult; aged; article; assisted circulation; diagnostic value; extracorporeal oxygenation; female; heart transplantation; human; implantation; lung disease; major clinical study; male; multivariate analysis; outcomes research; patient selection; priority journal; process optimization; regression analysis; resource allocation; risk factor; risk factor scaling score; scoring system; screening test; statistical significance; survival; treatment outcome; validation process; Adolescent; Adult; Aged; Blood Cell Count; Blood Chemical Analysis; Blood Urea Nitrogen; Extracorporeal Membrane Oxygenation; Female; Heart Transplantation; Heart-Assist Devices; Humans; Male; Middle Aged; Probability; Reproducibility of Results; Risk Factors; Survival Analysis; Treatment Failure; Treatment Outcome; Ventilator Weaning |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。